$17.66
-0.48-2.65%
al cierre: -
$17.66
0.000.00%
After hour: 4:00 PM EDT
Comments
Loading...
UroGen Pharma Actividad de operaciones con información privilegiada
URGNNASDAQ
Actividad de operaciones de insiders
Sigue la actividad de operaciones con información privilegiada más reciente de UroGen Pharma. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de UroGen Pharma.
¿Qué es la actividad interna?
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
¿Qué están haciendo UroGen Pharma Ltd los iniciados?
En UroGen Pharma Ltd, la reciente actividad interna ha llamado la atención. Durante los últimos 30 días, los insiders han informado que han vendido un total de - acciones por valor de -, mientras tanto, los insiders han no reportar compras en los últimos 30 días.
Compras y ventas recientes notables de información privilegiada
- El agosto 13, 2025, Mark Schoenberg, la empresa CHIEF MEDICAL OFFICER sold 10K acciones por $17.69 cada una.
Estadísticas de propiedad de UroGen Pharma Ltd
Acciones en circulación
46.264M
Acciones en manos de personas con información privilegiada
1.044M
Porcentaje de acciones en manos de personas con información privilegiada
2.26%
Acciones en manos de instituciones
10.249M
Porcentaje de acciones en manos de instituciones
22.2%
Oct 09, 2025 | CHIEF FINANCIAL OFFICER | 2.28K | $16.85 | -$37.12K | SELL-OPTIONS | ∞ | 2.28K | Oct 08 | ||
Sep 09, 2025 | CHIEF MEDICAL OFFICER | 796.00 | $19.11 | -$16.64K | SELL-OPTIONS | 0.54% | 149.03K | Sep 07 - Sep 08 | ||
Sep 09, 2025 | GENERAL COUNSEL | 1.81K | $19.11 | -$29.05K | SELL-OPTIONS | 4.37% | 43.30K | Sep 07 - Sep 08 | ||
Aug 13, 2025 | CHIEF MEDICAL OFFICER | -10.00K | $17.69 | -$176.90K | SELL | -6.32% | 148.23K | Aug 11 | ||
Jul 30, 2025 | GENERAL COUNSEL | 8.98K | $19.14 | -$143.97K | SELL-OPTIONS | 27.61% | 41.49K | Jul 28 | ||
Jul 30, 2025 | CHIEF MEDICAL OFFICER | 4.85K | $19.14 | -$98.55K | SELL-OPTIONS | 3.16% | 158.23K | Jul 28 | ||
Jun 11, 2025 | CHIEF MEDICAL OFFICER | 4.84K | $7.37 | -$38.04K | SELL-OPTIONS | 3.26% | 153.38K | Jun 08 - Jun 09 | ||
Feb 04, 2025 | CHIEF MEDICAL OFFICER | 3.45K | $11.14 | -$50.70K | SELL-OPTIONS | 2.38% | 148.54K | Jan 31 | ||
Feb 04, 2025 | GENERAL COUNSEL | 7.29K | $11.14 | -$82.20K | SELL-OPTIONS | 28.89% | 32.51K | Jan 31 | ||
Sep 12, 2024 | CHIEF MEDICAL OFFICER | 807.00 | $13.08 | -$11.24K | SELL-OPTIONS | 0.56% | 145.09K | Sep 09 | ||
Sep 12, 2024 | GENERAL COUNSEL | 1.81K | $13.08 | -$19.89K | SELL-OPTIONS | 7.74% | 25.23K | Sep 09 | ||
Jun 11, 2024 | CHIEF MEDICAL OFFICER | 4.85K | $13.08 | -$67.40K | SELL-OPTIONS | 3.48% | 144.28K | Jun 10 | ||
Mar 20, 2024 | CHIEF MEDICAL OFFICER | -12.00K | $14.05 | -$168.60K | SELL | -7.92% | 139.44K | Mar 18 | ||
Feb 02, 2024 | GENERAL COUNSEL | 5.01K | $15.74 | -$78.59K | SELL-OPTIONS | 27.20% | 23.41K | Jan 31 | ||
Feb 02, 2024 | CHIEF MEDICAL OFFICER | 2.88K | $15.74 | -$59.64K | SELL-OPTIONS | 1.94% | 151.44K | Jan 31 | ||
Sep 05, 2023 | GENERAL COUNSEL | 4.53K | $18.01 | -$68.44K | SELL-OPTIONS | 32.68% | 18.41K | Aug 31 | ||
Feb 02, 2023 | GENERAL COUNSEL | 1.70K | $10.12 | -$16.56K | SELL-OPTIONS | 13.94% | 13.87K | Jan 31 | ||
Feb 02, 2023 | CHIEF MEDICAL OFFICER | 1.93K | $10.12 | -$19.23K | SELL-OPTIONS | 1.32% | 148.56K | Jan 31 | ||
Nov 02, 2022 | CHIEF MEDICAL OFFICER | 242.00 | $11.85 | -$3.06K | SELL-OPTIONS | 1.02% | 23.95K | Oct 31 | ||
Sep 02, 2022 | GENERAL COUNSEL | 4.73K | $7.21 | -$26.00K | SELL-OPTIONS | 63.46% | 12.18K | Aug 31 | ||
Aug 25, 2022 | CHIEF MEDICAL OFFICER | 241.00 | $7.81 | -$2.02K | SELL-OPTIONS | 1.03% | 23.71K | Jul 31 - Aug 01 | ||
May 03, 2022 | CHIEF MEDICAL OFFICER | 246.00 | $6.62 | -$1.68K | SELL-OPTIONS | 1.06% | 23.47K | Apr 30 | ||
Feb 02, 2022 | GENERAL COUNSEL | 419.00 | $7.58 | -$3.14K | SELL-OPTIONS | 5.96% | 7.45K | Jan 31 | ||
Feb 02, 2022 | CHIEF FINANCIAL OFFICER | 335.00 | $7.58 | -$2.51K | SELL-OPTIONS | 6.82% | 5.25K | Jan 31 | ||
Feb 02, 2022 | CHIEF MEDICAL OFFICER | 1.13K | $7.58 | -$10.41K | SELL-OPTIONS | 5.10% | 23.22K | Jan 31 | ||
Feb 02, 2022 | CHIEF EXECUTIVE OFFICER | 10.14K | $7.58 | -$62.12K | SELL-OPTIONS | 3.40% | 308.36K | Jan 31 | ||
Jan 28, 2022 | CHIEF MEDICAL OFFICER | 98.00 | $8.09 | -$897.99 | SELL-OPTIONS | 0.45% | 22.09K | Jan 26 | ||
Jan 07, 2022 | CHIEF EXECUTIVE OFFICER | 58.72K | $9.15 | -$429.76K | SELL-OPTIONS | 24.52% | 298.22K | Jan 03 - Jan 04 | ||
Dec 02, 2021 | GENERAL COUNSEL | 4.53K | $12.03 | -$45.75K | SELL-OPTIONS | 181.20% | 7.03K | Nov 30 | ||
Dec 02, 2021 | CHIEF FINANCIAL OFFICER | 2.41K | $12.03 | -$31.12K | SELL-OPTIONS | 96.52% | 4.91K | Nov 30 | ||
Nov 19, 2021 | CHIEF MEDICAL OFFICER | 160.00 | $13.10 | $2.10K | BUY | 0.73% | 22.00K | Nov 18 | ||
Nov 02, 2021 | CHIEF MEDICAL OFFICER | 242.00 | $17.16 | -$4.43K | SELL-OPTIONS | 1.12% | 21.84K | Oct 31 - Nov 01 | ||
Oct 28, 2021 | CHIEF MEDICAL OFFICER | 101.00 | $16.32 | -$1.75K | SELL-OPTIONS | 0.47% | 21.59K | Oct 26 - Oct 27 | ||
Aug 03, 2021 | CHIEF MEDICAL OFFICER | 257.00 | $15.64 | -$3.80K | SELL-OPTIONS | 1.21% | 21.49K | Jul 31 - Aug 02 | ||
Jul 28, 2021 | CHIEF MEDICAL OFFICER | -311.00 | $15.30 | -$1.58K | SELL | -1.47% | 20.82K | Jul 26 | ||
May 18, 2021 | CHIEF FINANCIAL OFFICER | 2.50K | $15.85 | $39.63K | BUY | ∞ | 2.50K | May 17 | ||
May 18, 2021 | GENERAL COUNSEL | 2.50K | $15.71 | $39.27K | BUY | ∞ | 2.50K | May 17 | ||
May 04, 2021 | CHIEF MEDICAL OFFICER | 257.00 | $20.00 | -$4.86K | SELL-OPTIONS | 1.23% | 21.13K | Apr 30 | ||
Apr 27, 2021 | CHIEF MEDICAL OFFICER | 120.00 | $19.63 | -$1.75K | SELL-OPTIONS | 0.58% | 20.88K | Apr 26 | ||
Feb 02, 2021 | CHIEF MEDICAL OFFICER | 924.00 | $22.07 | -$23.75K | SELL-OPTIONS | 4.66% | 20.75K | Jan 31 | ||
Jan 26, 2021 | CHIEF MEDICAL OFFICER | 108.00 | $22.12 | -$2.21K | SELL-OPTIONS | 0.55% | 19.83K | Jan 26 | ||
Dec 15, 2020 | — | 10.00K | $18.50 | $185.00K | PURCHASE | 4.56% | 229.12K | Dec 14 | ||
Dec 07, 2020 | — | 380.00 | $19.85 | -$13.14K | OPTION EXERCISE | 1.96% | 19.72K | Dec 04 | ||
Oct 28, 2020 | — | 107.00 | $20.95 | -$2.12K | OPTION EXERCISE | 0.56% | 19.34K | Oct 26 |
PREGUNTAS FRECUENTES
¿Es legal el uso de información privilegiada?
Las operaciones con información privilegiada son legales siempre que se notifiquen a la Comisión de Bolsa y Valores (SEC). El comercio ilegal de valores se produce cuando la persona con información privilegiada viola un deber fiduciario o no informa de sus operaciones.
¿Cuáles son algunos ejemplos de manipulación del mercado?
Las operaciones con información privilegiada, los esquemas de pump and dump, el front running y las operaciones de lavado son ejemplos de manipulación del mercado. Los inversores que siguen el movimiento de activos con información privilegiada deben pensar atentamente por qué estos operadores con información privilegiada están negociando sus acciones antes de seguir adelante.
Explora operaciones con información privilegiada sobre todos los valores.